• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无法从主动性语义干扰中恢复过来预示着患有遗忘型轻度认知障碍的老年人日常功能衰退的轨迹。

Failure to recover from proactive semantic interference predicts trajectory of decline in everyday function among older adults with amnestic mild cognitive impairment.

作者信息

Zheng D Diane, Cid Rosie E Curiel, Ortega Alexandra, Crocco Elizabeth A, Vaillancourt David, Armstrong Melissa J, Asken Breton, DeKosky Steven T, Adjouadi Malek, Smith Glenn, Duara Ranjan, Marsiske Michael, Rosselli Monica, W Barker Warren, Loewenstein David A

机构信息

Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States.

Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States; 1Florida Alzheimer's Disease Research Center, Gainesville, FL 32610, United States.

出版信息

Int Psychogeriatr. 2025 Mar;37(2):100005. doi: 10.1016/j.inpsyc.2024.100005. Epub 2024 Dec 4.

DOI:10.1016/j.inpsyc.2024.100005
PMID:40086908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12101575/
Abstract

OBJECTIVES

To evaluate the predictive utility of proactive semantic interference (PSI) and failure to recover from proactive semantic interference (frPSI) deficits on the longitudinal everyday functional decline on the Clinical Dementia Rating Sum of Boxes (CDR-SOB) among older adults with amnestic mild cognitive impairment (aMCI).

DESIGN

Longitudinal prospective cohort study.

SETTING

1Florida Alzheimer's Disease Research Center (1FLADRC).

PARTICIPANTS

97 older adults aged 54 to 98 years who were diagnosed with aMCI following a baseline evaluation. The average age was 71.9 years, 51 % male, average education 15.7 years, and 56 % Hispanic. The mean MMSE score was 28.0. Participants were followed annually for 3 to 4 visits with a mean follow-up time of 38.9 months (range 22.7 to 70.3 months).

MEASUREMENTS

CDR-SOB were obtained at each visit and the latent growth curve trajectory of CDR-SOB was estimated. The associations between PSI and frPSI and the growth curve trajectory of CDR-SOB were examined.

RESULTS

The growth curve model that best fits the CDR-SOB trajectory was a linear form and included the fixed and random effect of intercept and slope of time. After adjusting for age, sex, education, Hispanic background, Hopkins Verbal Learning Test (HVLT) immediate and delayed recall, and amyloid positivity, frPSI (β = -0.134, se=0.04, p < 0.01) remained statistically significant in predicting a steeper slope on the trajectory of decline in CDR-SOB.

CONCLUSIONS

frPSI at baseline predicted the rate of everyday functional decline over time among participants with aMCI regardless of amyloid status and demonstrated its utility of longitudinal prediction of change in CDR-SOB.

摘要

目的

评估主动语义干扰(PSI)和无法从主动语义干扰中恢复(frPSI)缺陷对遗忘型轻度认知障碍(aMCI)老年人临床痴呆评定量表总和(CDR-SOB)纵向日常功能衰退的预测效用。

设计

纵向前瞻性队列研究。

设置

佛罗里达阿尔茨海默病研究中心(1FLADRC)。

参与者

97名年龄在54至98岁之间的老年人,他们在基线评估后被诊断为aMCI。平均年龄为71.9岁,51%为男性,平均受教育年限为15.7年,56%为西班牙裔。平均MMSE评分为28.0。参与者每年随访3至4次,平均随访时间为38.9个月(范围为22.7至70.3个月)。

测量

每次随访时获取CDR-SOB,并估计CDR-SOB的潜在生长曲线轨迹。检查PSI和frPSI与CDR-SOB生长曲线轨迹之间的关联。

结果

最适合CDR-SOB轨迹的生长曲线模型是线性形式,包括截距和时间斜率的固定效应和随机效应。在调整年龄、性别、教育程度、西班牙裔背景、霍普金斯言语学习测试(HVLT)即时和延迟回忆以及淀粉样蛋白阳性后,frPSI(β = -0.134,标准误 = 0.04,p < 0.01)在预测CDR-SOB下降轨迹上更陡的斜率方面仍具有统计学意义。

结论

基线时的frPSI预测了aMCI参与者随时间的日常功能衰退率,无论淀粉样蛋白状态如何,并证明了其对CDR-SOB变化进行纵向预测的效用。

相似文献

1
Failure to recover from proactive semantic interference predicts trajectory of decline in everyday function among older adults with amnestic mild cognitive impairment.无法从主动性语义干扰中恢复过来预示着患有遗忘型轻度认知障碍的老年人日常功能衰退的轨迹。
Int Psychogeriatr. 2025 Mar;37(2):100005. doi: 10.1016/j.inpsyc.2024.100005. Epub 2024 Dec 4.
2
Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments.预测认知正常的老年驾驶员停止驾驶的情况:阿尔茨海默病生物标志物和临床评估的作用。
Neurology. 2024 Jun 25;102(12):e209426. doi: 10.1212/WNL.0000000000209426. Epub 2024 Apr 15.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
5
Donepezil for vascular cognitive impairment.多奈哌齐用于治疗血管性认知障碍。
Cochrane Database Syst Rev. 2004(1):CD004395. doi: 10.1002/14651858.CD004395.pub2.
6
Predicting diagnostic conversion from mild cognitive impairment to Alzheimer's disease: A Bayesian hierarchical model approach using ADNI patient data.预测从轻度认知障碍到阿尔茨海默病的诊断转变:一种使用阿尔茨海默病神经影像倡议(ADNI)患者数据的贝叶斯分层模型方法。
J Alzheimers Dis. 2025 Jul 20;107(1):13872877251360228. doi: 10.1177/13872877251360228.
7
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中脑脊液淀粉样蛋白和 Tau 生物标志物的变化
JAMA Netw Open. 2025 Jul 1;8(7):e2519919. doi: 10.1001/jamanetworkopen.2025.19919.
8
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
9
The Association of Gabapentin Initiation with Cognitive and Behavioral Changes in Older Adults with Cognitive Impairment: A Retrospective Cohort Study.《老年认知障碍患者加巴喷丁起始治疗与认知和行为改变的关联:一项回顾性队列研究》。
Drugs Aging. 2024 Jul;41(7):623-632. doi: 10.1007/s40266-024-01130-z. Epub 2024 Jul 9.
10
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.认知正常或轻度认知障碍老年人的财务能力和大脑 Tau 与淀粉样蛋白负担的纵向演变。
J Prev Alzheimers Dis. 2024;11(4):966-974. doi: 10.14283/jpad.2023.121.

本文引用的文献

1
Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive.在淀粉样蛋白呈阳性的遗忘型轻度认知障碍患者中,语义侵入错误与血浆Ptau-181相关。
Front Neurol. 2023 Aug 4;14:1179205. doi: 10.3389/fneur.2023.1179205. eCollection 2023.
2
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
3
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB.利用临床试验和 ADNI 数据建立阿尔茨海默病进展模型,以预测 CDR-SB 的纵向轨迹。
CPT Pharmacometrics Syst Pharmacol. 2023 Jul;12(7):1029-1042. doi: 10.1002/psp4.12974. Epub 2023 May 2.
4
Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease.确立阿尔茨海默病导致轻度认知障碍临床试验中常用结局评估的临床有意义变化。
J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102.
5
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials.在 aducanumab 三期临床试验中,对早期阿尔茨海默病患者的暴露-临床痴呆评定量表-总评分关系进行特征描述。
J Pharmacokinet Pharmacodyn. 2023 Feb;50(1):45-62. doi: 10.1007/s10928-022-09839-3. Epub 2023 Jan 4.
6
A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease.新型认知挑战测试在临床前阿尔茨海默病评估中的应用综述。
Neuropsychology. 2023 Sep;37(6):661-672. doi: 10.1037/neu0000883. Epub 2022 Dec 8.
7
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
8
Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease.评估临床前阿尔茨海默病的显著认知范式。
Neurotherapeutics. 2022 Jan;19(1):89-98. doi: 10.1007/s13311-022-01192-0. Epub 2022 Mar 4.
9
Intrusion Errors and Progression of Cognitive Deficits in Older Adults with Mild Cognitive Impairment and PreMCI States.老年人轻度认知障碍和 PreMCI 状态下的认知缺陷的入侵错误和进展。
Dement Geriatr Cogn Disord. 2021;50(2):135-142. doi: 10.1159/000512804. Epub 2021 Jun 23.
10
The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults.语义侵入与轻度认知障碍不同病因亚型及认知健康老年人之间的关系。
Alzheimers Dement (Amst). 2021 May 25;13(1):e12192. doi: 10.1002/dad2.12192. eCollection 2021.